Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2009
07/02/2009WO2009079703A1 Elimination of contaminants associated with nucleic acid amplification
07/02/2009WO2009064771A3 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
07/02/2009WO2009060402A3 Plant promoters of the xvsap1 gene
07/02/2009WO2009060225A3 Rodenticide
07/02/2009WO2009059253A3 Methods for the economical production of biofuel from biomass
07/02/2009WO2009041830A3 Cell-permeabilising peptides and polypeptides for microbial cells
07/02/2009WO2009040092A3 Pna conjugates targeted to the emu enhancer of the igh locus as therapeutic agent for bcl-2 translocation driven follicular cell lymphoma clonal expansion
07/02/2009WO2009027527A3 Rna antagonist compounds for the modulation of fabp4/ap2
07/02/2009WO2008148068A8 Multicistronic vectors and methods for their design
07/02/2009WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual
07/02/2009WO2008031009A3 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
07/02/2009WO2008025527A8 Method for the production of insulin-like growth factor-i
07/02/2009WO2007134876A8 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY
07/02/2009WO2007090675A8 Novel oxidoreductases and uses thereof
07/02/2009WO2007085443A8 Genetic modification of homolactic thermophilic bacilli
07/02/2009WO2007084294A8 Epsps mutants
07/02/2009WO2007044033A9 Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
07/02/2009US20090172844 Engineering single-gene-controlled staygreen potential into plants
07/02/2009US20090172843 Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants as Well as its Application
07/02/2009US20090172842 Expression of recombinant genes encoding rubisco proteins in c3 plants
07/02/2009US20090172841 Useful for in transforming plants for tissue-preferred or constitutive expression of wild-type and variant forms of Zm-D9 proteins, for antisense suppression of the Zm-D9 gene, and for isolating homologous polynucleotide molecules that encode DELLA proteins
07/02/2009US20090172840 Nucleotide sequences and corresponding polypeptides conferring an altered flowering time in plants
07/02/2009US20090172839 Compositions and Methods of Increasing Stress Tolerance in Plants
07/02/2009US20090172838 Compositions and methods for efficient gene silencing in plants
07/02/2009US20090172837 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants
07/02/2009US20090172836 Resistance to Powdery Mildew and Absence of Necrosis in Cucumis Sativus
07/02/2009US20090172835 Flax (linum usitatissimum l.) seed-specific promotors
07/02/2009US20090172834 Proteins Associated With Abiotic Stress Response And Homologs
07/02/2009US20090172833 Nucleic Acid Molecules and Other Molecules Associated with Transcription in Plants
07/02/2009US20090172832 Expression of rubisco enzyme from a non-rubisco locus
07/02/2009US20090172831 Methods for the production of plants resistant to HPPD herbicides
07/02/2009US20090171639 Method to identify modulators for human 3alpha-hydroxysteroid dehydrogenase
07/02/2009US20090171077 Delivery of nucleic acid-like compounds
07/02/2009US20090171070 Process for the Purification of Recombinant Albumin
07/02/2009US20090170807 Methods and means for producing hyaluronan
07/02/2009US20090170802 Method for producing polymers
07/02/2009US20090170800 Genetic constructs and compositions comprising rre and cte and uses thereof
07/02/2009US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases
07/02/2009US20090170798 Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
07/02/2009US20090170795 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
07/02/2009US20090170794 Small interfering rnas that efficiently inhibit viral expression and methods of use thereof
07/02/2009US20090170793 Theophylline-dependent riboswitches which modulate RNA splicing; made by insertion of a high affinity theophylline binding aptamer into the 3' splice site region, 5' splice site region, or branchpoint sequence (BPS) of a pre-mRNA modulates RNA splicing in the presence of theophylline
07/02/2009US20090170792 Peptide ligands
07/02/2009US20090170775 Vasoactive intestinal polypeptide compositions
07/02/2009US20090170769 Cell surface receptor isoforms and methods of identifying and using the same
07/02/2009US20090170766 Chimeric Kunitz Domains and their Use
07/02/2009US20090170763 Modified gherlin peptides
07/02/2009US20090170750 Single-Chain Insulin
07/02/2009US20090170747 Cellulase variants
07/02/2009US20090170745 Subtilisin from bacillus pumilus and detergent and cleaning agents containing said novel subtilisin
07/02/2009US20090170727 Methods for dynamic vector assembly of dna cloning vector plasmids
07/02/2009US20090170722 Methods of constructing and screening diverse expression libraries
07/02/2009US20090170720 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
07/02/2009US20090170703 Disease Resistant Plants
07/02/2009US20090170206 Method for homologous recombination in eukaryotic cells
07/02/2009US20090170205 Method of maintenance and expansion of hematopoietic stem cells
07/02/2009US20090170204 Novel cosmetic designs and products using intronic RNA
07/02/2009US20090170203 Methods for female mammalian spermatogenesis and male mammalian oogenesis using synthetic nanobiology
07/02/2009US20090170201 Compositions and methods of making embryonic stem cells
07/02/2009US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
07/02/2009US20090170194 Teal fluorescent proteins
07/02/2009US20090170192 Methods and dna constructs for high yield production of polypeptides
07/02/2009US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
07/02/2009US20090170182 Lopap-based pharmaceutical compositions and uses thereof
07/02/2009US20090170181 EGVII Endoglucanase and Nucleic Acids Encoding The Same
07/02/2009US20090170173 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii
07/02/2009US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives
07/02/2009US20090170170 P2-10 expression units
07/02/2009US20090170165 Method for recombinant production in cho cells
07/02/2009US20090170164 Recombinant protein production in a human cell
07/02/2009US20090170162 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
07/02/2009US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression
07/02/2009US20090170160 Expression System
07/02/2009US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/02/2009US20090170157 Asparaginases
07/02/2009US20090170156 Hydroxynitrile lyase
07/02/2009US20090170155 Mutant Endoglycoceramidases With Enhanced Synthetic Activity
07/02/2009US20090170154 modified so as to have, as a genomic DNA or plasmid DNA, a DNA molecule which includes a sigA gene or a gene functionally equivalent thereto; capable of enhancing productivity of proteins or polypeptides
07/02/2009US20090170153 Effect of radiation on cellulase enzymes
07/02/2009US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof
07/02/2009US20090170145 contacting the test sample with the amide hydrolase, creatinine amidinohydrolase, and sarcosine oxidase so as to produce hydrogen peroxide, and detecting the level of H2o2;; accuracy, preciseness and can be made automatic
07/02/2009US20090170141 Ghrelin o-acyltransferase (goat) biochemical assay
07/02/2009US20090170122 Human intestinal NPT2B
07/02/2009US20090170109 Corn event tc1507 and methods for detection thereof
07/02/2009US20090170108 Screening method, a composition comprising substances chosen in the method thereof, and a binding substance
07/02/2009US20090170102 Methods for detecting dna originating from different individuals
07/02/2009US20090170099 Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells
07/02/2009US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto
07/02/2009US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
07/02/2009US20090170076 Polynucleotides for the detection of escherichia coli 0157:h7 and escherichia coli 0157:nm verotoxin producers
07/02/2009US20090170074 System and method for nucleic acid sequencing by polymerase synthesis
07/02/2009US20090170067 Simian tropic, recombinant human immunodeficiency-1 viruses
07/02/2009US20090170059 Methods for Preparing Cord Matrix Stem Cells (CMSC) for Long Term Storage and for Preparing a Segment of umbilical cord for cryopreservation
07/02/2009US20090169709 Promoter molecules for use in plants
07/02/2009US20090169638 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
07/02/2009US20090169634 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof
07/02/2009US20090169579 Modified vaccinia Ankara virus avriant
07/02/2009US20090169574 Heteroclitic analogs and related methods
07/02/2009US20090169573 T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use
07/02/2009US20090169571 Selected ma motifs to include cell death and/or apoptosis